Predictors of target lesion revascularization in patients undergoing lower extremity percutaneous interventions

Journal of Invasive Cardiology

Volumn 21, Issue 6, 2009, Pages 266-269

  Shammas, Nicolas W ^a,b   Shammas, Gail ^a   Bryan, Darren ^a   Rauba, Jason ^a   Dippel, Eric ^a   Jerin, Michael ^a  

^a MIDWEST CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^b Cardiovascular Medicine Davenport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE DISTRIBUTION; AGED; ANKLE BRACHIAL INDEX; ARTICLE; BLOOD VESSEL LENGTH; BLOOD VESSEL OCCLUSION; BLOOD VESSEL PARAMETERS; CLAUDICATION; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; LEG REVASCULARIZATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NONSURGICAL INVASIVE THERAPY; PERIPHERAL PERCUTANEOUS INTERVENTION; POPLITEAL ARTERY; PROSPECTIVE STUDY; SEX DIFFERENCE; TARGET LESION REVASCULARIZATION; TIBIAL ARTERY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; COMPLEMENT C5A; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; EXTREMITIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS;

EID: 69249105973     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kandarpa K, Becker GJ, Hunink MG, et al. Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: Part I. J Vasc Interv Radiol 2001;12:683-695. (Pubitemid 32521156)
2. Laird JR. Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries. J Endovasc Ther 2006;13(Suppl 2):II30-II40.
3. Shammas NW, Kapalis MJ, Dippel EJ, et al. Clinical and angiographic predictors of restenosis following renal artery stenting. J Invasive Cardiol 2004;16:10-13. (Pubitemid 38082470)
4. Dubé H, Clifford AG, Barry CM, et al. Comparison of the vascular responses to balloon-expandable stenting in the coronary and peripheral circulations: Long-term results in an animal model using the TriMaxx stent. J Vasc Surg 2007;45:821-827. (Pubitemid 46486769)
5. Schillinger M, Minar E. Restenosis after percutaneous angioplasty: The role of vascular inflammation. Vasc Health Risk Manag 2005;1:73-78.
6. Schillinger M, Exner M, Mlekusch W, et al. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis. Radiology 2002;225:21-26.
7. Schillinger M, Exner M, Mlekusch W, et al. Inflammatory response to stent implantation: Differences in femoropopliteal, iliac, and carotid arteries. Radiology 2002;224:529-535. (Pubitemid 34809137)
8. Schillinger M, Exner M, Mlekusch W, et al. Endovascular revascularization below the knee: 6-Month results and predictive value of C-reactive protein level. Radiology 2003;227:419-425. (Pubitemid 36514756)
9. Schillinger M, Exner M, Mlekusch W, et al. Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries. Thromb Haemost 2002;87:959-965. (Pubitemid 34624876)
10. Speidl WS, Exner M, Amighi J, et al. Complement component C5a predicts restenosis after superficial femoral artery balloon angioplasty. J Endovasc Ther 2007;14:62-69. (Pubitemid 46303311)
11. Laxdal E, Eide GE, Wirsching J, et al. Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoropopliteal artery. Eur J Vasc Endovasc Surg 2004;28:410-417. (Pubitemid 39207093)
12. Schillinger M, Exner M, Mlekusch W, et al. Restenosis after femoropopliteal PTA and elective stent implantation: Predictive value of monocyte counts. J Endovasc Ther 2003;10:557-565. (Pubitemid 37129217)
13. Ray B, Chetter IC, Lee HL, et al. Plasma tissue factor is a predictor for restenosis after femoropopliteal angioplasty. Br J Surg 2007;94:1092-1095. (Pubitemid 350082853)
14. Schillinger M, Haumer M, Schlerka G, et al. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: The role of inflammation. J Endovasc Ther 2001;8:477-483. (Pubitemid 33032462)
15. Hunink MG, Donaldson MC, Meyerovitz MF, et al. Risks and benefits of femoropopliteal percutaneous balloon angioplasty. J Vasc Surg 1993;17:183-192.
16. Davies MG, Saad WE, Peden EK, et al. Percutaneous superficial femoral artery interventions for claudication - Does runoff matter? Ann Vasc Surg 2008 Jul 18. [Epub ahead of print].
17. Abando A, Akopian G, Katz SG. Patient sex and success of peripheral percutaneous transluminal arterial angioplasty. Arch Surg 2005;140:757-761. (Pubitemid 41175700)
18. Gallino A, Mahler F, Probst P, Nachbur B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: A 5 year follow-up. Circulation 1984;70:619-623. (Pubitemid 14020659)
19. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation 1991;83(2 Suppl):I70-I80.
20. Van Laanen J, Hendriks JM, Van Sambeek MR. Factors influencing restenosis after carotid aretery stenting. J Cardiovasc Surg 2008;49:743-747.
21. Timaran CH, Stevens SL, Freeman MB, Goldman MH. External iliac and common iliac artery angioplasty and stenting in men and women. J Vasc Surg 2001;34:440-446. (Pubitemid 33661176)
22. Maca T, Ahmadi R, Derfler K, et al. Elevated lipoprotein(a) and increased incidence of restenosis after femoropopliteal PTA. Rationale for the higher risk of recurrence in females? Atherosclerosis 1996;127:27-34. (Pubitemid 26425839)
23. DeRubertis BG, Vouyouka A, Rhee SJ, et al. Percutaneous intervention for infrainguinal occlusive disease in women: Equivalent outcomes despite increased severity of disease compared with men. J Vasc Surg 2008;48:150-157 (Pubitemid 351863752)
24. Park B, Aiello F, Dahn MS, et al. No gender influences on clinical outcomes or durability of repair following carotid angioplasty with stenting and carotid endarterectomy. Vasc Endovascular Surg 2008;42:321-328.